A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : DA / disease activity

[Related PubMed/MEDLINE]
Total Number of Papers: 36
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   DA  (>> Co-occurring Abbreviation)
Long Form:   disease activity
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Disease-specific quality of life following a flare in systemic lupus erythematosus: an item response theory analysis of the French EQUAL cohort. HRQoL, SFI, SFI-R
2019 NEMO score in nailfold videocapillaroscopy is a good tool to assess both steady state levels and overtime changes of disease activity in patients with systemic sclerosis: a comparison with the proposed composite indices for this disease status entity. EScSG, EUSTAR, MHEs, MTs, ROC, SSc
2019 Rheumatoid arthritis disease activity and the risk of aseptic arthroplasty loosening. OA, RA, RCL, SDAI, THA/TKA
2019 Treat-to-target and shared decision making in rheumatoid arthritis treatment: Is it feasible? RA, SA, SDM
2018 Evaluation of sleep quality in patients with ankylosing spondylitis and efficacy of anti-TNF-alpha therapy on sleep problems: A polisomnographic study. anti-TNFalpha, AS, PSG, PSQI, SQ
2018 Feasibility and reliability of the Spondyloarthritis Research Consortium of Canada sacroiliac joint inflammation score in children. ICC, ICCs, JSpA, MRI, SIS, SPARCC
2018 TNF-alpha and plasma albumin as biomarkers of disease activity in systemic lupus erythematosus. BILAG, PtGDA, SLAM, SLE
2017 Are interferon-related biomarkers advantageous for monitoring disease activity in systemic lupus erythematosus? A longitudinal benchmark study. IP-10, SIGLEC1
2017 Delayed conventional DMARDs therapy is effective in Rheumatoid Arthritis. CDAI, DMARDs, JPMC, RA
10  2017 Evaluation of Serum Trace Element Levels and Superoxide Dismutase Activity in Patients with Inflammatory Bowel Disease: Translating Basic Research into Clinical Application. CD, IBD, SOD, UC
11  2017 Implementing Treat-to-Target Practices for Chronic Pain Through Shared Decision Making: Requisites, Prospects, and Challenges. ---
12  2017 Lipid profile in early arthritis and its relation with inflammatory activity EA
13  2017 The added value of musculoskeletal ultrasound to clinical evaluation in the treatment decision of rheumatoid arthritis outpatients: physician experience matters. GUS-7, PD, SR, TR
14  2017 The cumulative number of micro-haemorrhages and micro-thromboses in nailfold videocapillaroscopy is a good indicator of disease activity in systemic sclerosis: a validation study of the NEMO score. ESSG, GCs, MHEs, MTs, nCs, NVC, SSc
15  2017 The evaluation of sleep quality and response to anti-tumor necrosis factor alpha therapy in rheumatoid arthritis patients. anti-TNFalpha, PSG, PSQI, RA, SQ
16  2016 A multi-biomarker follow-up study of patients with multiple sclerosis. CIS, CSF, RRMS
17  2016 Disease Activity Does Not Explain It All: How Internalizing Symptoms and Caregiver Depressive Symptoms Relate to Health-related Quality of Life Among Youth with Inflammatory Bowel Disease. HRQoL
18  2016 Increased healthcare resource utilization in higher disease activity levels in initiators of TNF inhibitors among US rheumatoid arthritis patients. CDAI, HCRU, IRR, M/HDA, py, RA, TNFis
19  2016 Interpreting the multi-biomarker disease activity score in the context of tocilizumab treatment for patients with rheumatoid arthritis. IL-6, MBDA, RA, TCZ
20  2016 Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients. SLE
21  2016 Ultrasound assessment of enthesis thickening in psoriatic arthritis patients treated with adalimumab compared to methotrexate. ADA, AT, ET, FT, IE, MTX, PA, PAI, PsA, SJ, US, VAS
22  2016 Validity of data collected in BIOREG, the Austrian register for biological treatment in rheumatology: current practice of bDMARD therapy in rheumatoid arthritis in Austria. AEs, bDMARDs, csDMARDs, GC, RA
23  2016 Vasculitic central retinal vein occlusion: The presenting sign of seronegative rheumatoid arthritis. CRVO, RA
24  2016 [Electrocardiographic changes and QT interval modifications in patients with Early Arthritis]. EA
25  2015 Lengthening the time intervals between doses of biological agents in psoriatic arthritis patients: A single-center retrospective study. MDA, PsA, TNF
26  2014 Nailfold videocapillaroscopy micro-haemorrhage and giant capillary counting as an accurate approach for a steady state definition of disease activity in systemic sclerosis. AUC, Cs, ESSG, GC, MHE, MT, NEMO, NVC, SSc
27  2013 Behcet's disease: new insight into the relationship between procoagulant state, endothelial activation/damage and disease activity. BD, CAT, CRP, ES, PAI-1, ROTEM, TAT
28  2013 IFNalpha and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosus. BILAG-2004, IFN, IP-10, Siglec-1, SLE
29  2012 Bone mineral density changes during treatment of rheumatoid arthritis with disease-modifying-anti-rheumatic drugs. BMD, DXA, MTX, RA
30  2012 Evaluation of Ankylosing Spondylitis Quality of Life questionnaire: responsiveness of a new patient-reported outcome measure. EASi-QoL, ES, ETN, EWB, MIC, PF, SP
31  2009 Parent quality of life in the context of pediatric inflammatory bowel disease. IBD, MH, PH, QOL
32  2006 Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. CF, Hb, IBD, QOL
33  1999 A comparative study of the usefulness of the Bath Ankylosing Spondylitis Functional Index and the Dougados Functional Index in the assessment of ankylosing spondylitis. AS, BASDAI, SASSS, VAS
34  1997 Imbalance of tissue-type plasminogen activator (t-PA) and its specific inhibitor (PAI-1) in patients with rheumatoid arthritis associated with disease activity. DD, RA, SI, tPA
35  1996 A prospective study of the relationship between disease activity and psychologic distress in patients with inflammatory bowel disease. HADS, IBD
36  1996 Elevated levels of markers of endothelial cell damage and markers of activated coagulation in patients with systemic necrotizing vasculitis. ANCA, MP, TAT, TM, vWF, WG